Epinephrine bitartrate
Sold as Pharma-q adrenaline, Episup junior auto-injector, Adrenoject, Adrenaline-fresenius (1:1000), Medihaler epi d, Medihaler epi
4-[(1R)-1-Hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
Drag to rotate. Structure from PubChem CID 5816.
Background
Registration
- Applicants
- 6
- Registrations
- 6
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharma-q Holdings (Pty) Ltd | Pharma-q adrenaline | 1 mg/ml | 300395 | Not determined | None |
| Viatris Healthcare (Pty) Ltd | Episup junior auto-injector | Not stated | 600450 | Not determined | None |
| Adcock ingram limitedCancelled | Adrenoject | Not stated | C0703 | Not determined | None |
| Fresenius Medical Care South Africa (Pty) Ltd | Adrenaline-fresenius (1:1000) | 1 mg/1 ml | C0923 | Not determined | None |
| Riker Laboratory SA (Pty) LtdCancelled | Medihaler epi d | 200 | G0843 | Not determined | None |
| Inova Pharmaceuticals (Pty) Ltd | Medihaler epi | Not stated | G0844 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharma-q adrenaline injection 1 mg/ml EACH 1 ml LIQUID CONTAINS EPINEPHRINE BITARTRATE 1,80 mg EQUIVALENT TO EPINEPHRINE 1 mg | 1 mg/mlInjection | 30039530/5.1/0395 | Registered | Not determined | None |
| Episup junior auto-injector EACH 0,3 ml SOLUTION CONTAINS: EPINEPHRINE BITARTRATE 0,15 mg | Not listed | 60045060/5.1/0450 | Registered | Not determined | None |
| Adrenoject EACH 1 ml CONTAINS EPINEPHRINE BITARTRATE A 1,8 mg | Not listed | C0703 | Cancelled | Not determined | None |
| Adrenaline-fresenius1 mg/1 ML (1:1000) EACH 1,0 ml SOLUTION CONTAINS EPINEPHRINE BITARTRATE A 1,0 mg | 1 mg/1 ml | C0923 | Old Medicine | Not determined | None |
| Medihaler epi 200 d 1 ML EPINEPHRINE BITARTRATE A 14,0 MG | 200 | G0843 | Cancelled | Not determined | None |
| Medihaler epi 1 ML EPINEPHRINE BITARTRATE A 14,0 MG | Not listed | G0844 | Old Medicine | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S4: Epinephrine
- when intended for injection.
Consolidated Schedules 06 July 2026, line 6203
S3: Adrenaline
- ophthalmic preparations thereof, when intended for glaucoma.
Consolidated Schedules 06 July 2026, line 3122
S2: Adrenaline
- ophthalmic preparations when intended for glaucoma, and
- preparations for injection. (S3, S4)
Consolidated Schedules 06 July 2026, lines 1561 to 1565
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.